论文部分内容阅读
目的探讨血清肿瘤标志物CEA、CA125对乳腺癌患者的诊断价值。方法选取2009年3月至2010年3月,来我院就诊的50例乳腺癌的患者,选取健康群体30例作为对照组,50例乳腺癌的患者作为观察组,检测两组患者的血清中的CEA、CA125。结果对照组血清中的CEA、CA125水平明显低于观察组的水平,观察组术前和术后血清中的CEA、CA125水平对比,术后远远低于术前的水平。两组患者对比差异具有统计学意义(P<0.05)。结论检测血清中的CEA、CA125水平,对乳腺癌的诊断具有重要的作用,而且操作简单价格便宜,可重复性强,值得临床广泛推广。
Objective To investigate the diagnostic value of serum tumor markers CEA and CA125 in patients with breast cancer. Methods From March 2009 to March 2010, 50 patients with breast cancer from our hospital were enrolled. Thirty healthy subjects were selected as the control group. Fifty patients with breast cancer were selected as the observation group. Serum Of CEA, CA125. Results Serum levels of CEA and CA125 in the control group were significantly lower than those in the observation group. The levels of CEA and CA125 in the serum before and after the operation in the observation group were significantly lower than those before operation. The difference between the two groups was statistically significant (P <0.05). Conclusion The detection of serum CEA and CA125 levels plays an important role in the diagnosis of breast cancer. The method is simple, inexpensive, reproducible and worthy of widespread clinical application.